ArticleClinical and experimental nephrology2026

Rituximab vs. cyclophosphamide in treatment-naive IMN: efficacy and renal protection in early renal impairment.

Qi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.